4//SEC Filing
Deniger Drew 4
Accession 0000899243-22-031464
CIK 0001107421other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:30 PM ET
Size
11.4 KB
Accession
0000899243-22-031464
Insider Transaction Report
Form 4
Deniger Drew
VP, Research and Development
Transactions
- Award
Employee Stock Option (right to buy)
2022-09-15+305,000→ 305,000 totalExercise: $2.11Exp: 2032-09-14→ Common Stock (305,000 underlying)
Footnotes (1)
- [F1]The options will vest in a series of sixteen equal quarterly installments measured from September 15, 2022, with the first vesting occurring on December 15, 2022, subject to the Reporting Person's continuous service through each such date.
Issuer
Alaunos Therapeutics, Inc.
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001921961
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 4:30 PM ET
- Size
- 11.4 KB